COMP <GO>
ENOV vs ESTA // ALTMAN Z-SCORE & DEBT/EQUITY
Enovis Corporation (NYSE) VS. Establishment Labs Holdings Inc. (NASDAQ) • 15-METRIC TALLY: ENOV 3
— ESTA 7
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: ESTA
LAST: $22.81 (+4.11%) • MKT CAP: $1.32B
balance-sheet
0.20
LAST: $68.41 (-0.81%) • MKT CAP: $2.04B
balance-sheet
2.52
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ENOV VS. ESTA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ENOV | ESTA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 59.80% | 69.30% | -9.50 | ESTA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.70% | -15.80% | -16.90 | ESTA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.51% | -2.79% | +4.30 | ENOV | /fcf-yield <GO> |
| Operating Margin | -50.00% | -18.50% | -31.50 | ESTA | /operating-margins <GO> |
| Net Profit Margin | -52.70% | -24.20% | -28.50 | ESTA | /net-margins <GO> |
| Revenue Growth (YoY) | 6.70% | 27.10% | -20.40 | ESTA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 0.20 | 2.52 | -2.32 | ESTA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | ENOV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.3 | 44.9 | +3.40 | ENOV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.32B | $2.04B | -$723.3M | ESTA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ENOV REV | ESTA REV | ENOV GROSS % | ESTA GROSS % | ENOV FCF | ESTA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.25B | $211.1M | 59.8% | 69.3% | $19.9M | -$56.9M |
| FY 2024 | $2.11B | $166.0M | 56.0% | 66.0% | -$67.2M | -$64.6M |
| FY 2023 | $1.71B | $165.2M | — | — | $135.0M | -$88.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ENOV // BETA —
ESTA // BETA —